Your browser doesn't support javascript.
loading
S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells.
Nagira, Yoji; Nagira, Morio; Nagai, Ryohei; Nogami, Wataru; Hirata, Michinari; Ueyama, Azumi; Yoshida, Tetsuya; Yoshikawa, Mai; Shinonome, Satomi; Yoshida, Hiroshi; Haruna, Miya; Miwa, Hiroto; Chatani, Natsumi; Ohkura, Naganari; Wada, Hisashi; Tanaka, Hidekazu.
Affiliation
  • Nagira Y; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Nagira M; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Nagai R; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Nogami W; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Hirata M; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Ueyama A; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Yoshida T; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Yoshikawa M; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Shinonome S; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Yoshida H; Department of Basic Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Haruna M; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Miwa H; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Chatani N; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Ohkura N; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Wada H; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Tanaka H; Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
Mol Cancer Ther ; 22(9): 1063-1072, 2023 09 05.
Article in En | MEDLINE | ID: mdl-37420296
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chemokine / Neoplasms Limits: Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chemokine / Neoplasms Limits: Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2023 Type: Article Affiliation country: Japan